Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

N Engl J Med. 2017 Mar 2;376(9):891. doi: 10.1056/NEJMc1615712.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cardiovascular Diseases
  • Diabetes Mellitus, Type 2*
  • Glycated Hemoglobin*
  • Humans

Substances

  • Glycated Hemoglobin A